Tens of Thousands at Risk as States Slash HIV Drug Assistance Programs

WASHINGTON — March 4, 2026

A growing fiscal crisis is unfolding across the United States as nearly 20 states have moved to restrict access to life-saving medications for low-income residents living with HIV. According to a new report from health policy research group KFF, tens of thousands of Americans are facing immediate disruptions to their healthcare as state-run AIDS Drug Assistance Programs (ADAPs) implement drastic cost-containment measures.

The restrictions, which include lowering income eligibility and removing common medications from approved lists, come as federal funding remains stagnant despite a 30% surge in program enrollment over the last two years. Public health experts warn that even brief interruptions in treatment could lead to a resurgence of the virus, the development of drug-resistant strains, and a sharp increase in new transmissions.

The Epicenter: Florida’s “Public Health Disaster”

Florida has emerged as the most visible example of this shifting landscape. Effective March 1, 2026, the Florida Department of Health (DOH) enacted an emergency rule that slashed ADAP income eligibility from 400% of the Federal Poverty Level (FPL) to just 130%.

For a single individual, this means the maximum annual income to qualify for assistance dropped from approximately $64,000 to roughly $21,000. Advocates estimate that this change alone will strip benefits from more than 16,000 residents.

Beyond eligibility, Florida has removed Biktarvy—a once-daily pill that is the most widely prescribed HIV treatment in the U.S.—from its direct-dispensing formulary.

“This is an economic disaster, a public health disaster, and a moral disaster,” said Esteban Wood, Director of Advocacy and Legislative Affairs for the AIDS Healthcare Foundation (AHF). “We are receiving hundreds of calls from patients in tears, asking how they are supposed to survive. For someone earning $25,000, these medications can cost $45,000 a year out of pocket. That isn’t a gap; it’s a cliff.”

The AHF has filed a legal petition against the Florida DOH, alleging the state bypassed mandatory rulemaking procedures and failed to provide adequate notice to vulnerable patients.

A Nationwide Trend of Contraction

While Florida’s cuts are the most severe, they are not isolated. New data from the National Association of State and Territorial AIDS Directors (NASTAD) indicate that 23 states and Washington, D.C., have implemented or are considering cost-containment measures.

Other states, including Arizona, Michigan, and Nevada, have tightened recertification requirements or reduced the scope of their drug formularies to remain solvent.

The “Perfect Storm”: Why Now?

The crisis is the result of three converging factors:

1. The Medicaid “Unwinding”: During the COVID-19 pandemic, federal rules prevented states from removing people from Medicaid. When those protections expired in 2023 and 2024, thousands of people with HIV lost their primary insurance and shifted to ADAP as the “payer of last resort.”

2. Flat Federal Funding: Despite the influx of new clients, federal appropriations for the Ryan White Program Part B (which funds ADAPs) have remained largely unchanged for over a decade.

3. Rising Costs: The price of advanced antiretroviral therapies (ART) and private insurance premiums has climbed steadily, exhausting state budgets.

Clinical and Public Health Implications

The clinical stakes of these administrative changes are high. Modern HIV treatment relies on Viral Suppression—reducing the amount of virus in the blood to “undetectable” levels. When a person is undetectable, they cannot transmit the virus to others, a concept known as U=U (Undetectable = Untransmittable).

Treatment interruptions can cause the viral load to “rebound” rapidly. “HIV treatment disruptions of this magnitude will result in a public health disaster,” warned Dr. Anna K. Person, chair of the HIV Medicine Association (HIVMA). “Any potential interruption has the potential to increase the rate of uncontrolled virus and worsen outcomes for the entire community.”

A simulation study presented at the 2026 Conference on Retroviruses and Opportunistic Infections (CROI) suggested that if the Ryan White safety net were to fail entirely, new HIV infections in the U.S. could soar by 73% over the next five years.

The Path Forward

For those currently affected, particularly in Florida, the Centers for Medicare & Medicaid Services (CMS) has opened a special enrollment period running through April 30, 2026. This allows residents losing ADAP coverage to select new private insurance plans through the federal marketplace. However, advocates note that many patients remain unaware of this window or struggle to navigate the complex insurance landscape without professional assistance.

As the 2027 federal budget cycle begins, HIV organizations are urging Congress to move beyond “level funding” and provide the investment necessary to sustain the “Ending the HIV Epidemic” (EHE) initiative.

“Each HIV infection prevented saves an estimated half-million dollars in lifetime treatment costs,” said Carl Baloney, Jr., CEO of AIDS United. “Cutting public health infrastructure now is cutting our future.”

Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.

References

• https://www.daijiworld.com/news/newsDisplay?newsID=1308054